Bezafibrate Treatment and Reduced Risk of Cancer

Dr. Zaza Iakobishvili, Director of the Community Cardiology Department in Tel Aviv Jaffa District, in Israel, shares results of his study appearing in the July 2019 issue of Mayo Clinic Proceedings, which found a significant reduction in cancer rates for patients with coronary artery disease being treated with Bezafibrate across all cancers except non-small cell lung cancer. Available at: https://mayocl.in/2Z8AnzZ